WUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million

Bulletin Express06-03

WUXI BIO (Cayman) Inc. disclosed a minor increase and a larger planned reduction in share capital as of 3 June 2026.

• New shares issued On 2 June 2026, 102,000 ordinary shares were allotted upon exercise of Pre-IPO Share Option Scheme options at HKD 1.72 per share, expanding the issued share base by 0.00246 % to 4.14 billion shares.

• Ongoing share buy-backs Between 27 May and 3 June 2026, the company bought back 7.47 million shares pending cancellation, including 1.51 million shares repurchased on-market on 3 June at prices between HKD 32.52 and HKD 33.82, for a total consideration of HKD 49.89 million.

Cumulatively, 30.65 million shares (0.75 % of the share capital authorised under the current mandate dated 6 June 2025) have been repurchased since the mandate’s adoption. A 30-day moratorium on new share issues runs until 3 July 2026.

• Share capital position Issued shares outstanding: 4,141.01 million Treasury shares: none Shares pending cancellation from recent buy-backs: 7.47 million

All transactions were executed in compliance with Hong Kong Stock Exchange listing rules and the company’s repurchase mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113243608?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 22:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113243608","market":"us","top_or_hot":-1,"title":"WUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million","media":"Bulletin Express","content":"<p>WUXI BIO (Cayman) Inc. disclosed a minor increase and a larger planned reduction in share capital as of 3 June 2026.</p>\n<p>• New shares issued  \nOn 2 June 2026, 102,000 ordinary shares were allotted upon exercise of Pre-IPO Share Option Scheme options at HKD 1.72 per share, expanding the issued share base by 0.00246 % to 4.14 billion shares.</p>\n<p>• Ongoing share buy-backs  \nBetween 27 May and 3 June 2026, the company bought back 7.47 million shares pending cancellation, including 1.51 million shares repurchased on-market on 3 June at prices between HKD 32.52 and HKD 33.82, for a total consideration of HKD 49.89 million.</p>\n<p>Cumulatively, 30.65 million shares (0.75 % of the share capital authorised under the current mandate dated 6 June 2025) have been repurchased since the mandate’s adoption. A 30-day moratorium on new share issues runs until 3 July 2026.</p>\n<p>• Share capital position  \nIssued shares outstanding: 4,141.01 million  \nTreasury shares: none  \nShares pending cancellation from recent buy-backs: 7.47 million</p>\n<p>All transactions were executed in compliance with Hong Kong Stock Exchange listing rules and the company’s repurchase mandate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWUXI BIO Issues 0.10 Million New Shares Under Pre-IPO Options, Repurchases 1.51 Million Shares for HKD 49.89 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WUXI BIO (Cayman) Inc. disclosed a minor increase and a larger planned reduction in share capital as of 3 June 2026.</p>\n<p>• New shares issued  \nOn 2 June 2026, 102,000 ordinary shares were allotted upon exercise of Pre-IPO Share Option Scheme options at HKD 1.72 per share, expanding the issued share base by 0.00246 % to 4.14 billion shares.</p>\n<p>• Ongoing share buy-backs  \nBetween 27 May and 3 June 2026, the company bought back 7.47 million shares pending cancellation, including 1.51 million shares repurchased on-market on 3 June at prices between HKD 32.52 and HKD 33.82, for a total consideration of HKD 49.89 million.</p>\n<p>Cumulatively, 30.65 million shares (0.75 % of the share capital authorised under the current mandate dated 6 June 2025) have been repurchased since the mandate’s adoption. A 30-day moratorium on new share issues runs until 3 July 2026.</p>\n<p>• Share capital position  \nIssued shares outstanding: 4,141.01 million  \nTreasury shares: none  \nShares pending cancellation from recent buy-backs: 7.47 million</p>\n<p>All transactions were executed in compliance with Hong Kong Stock Exchange listing rules and the company’s repurchase mandate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1113243608","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113243608","pubTimestamp":1780497001,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"WUXI BIO (Cayman) Inc. disclosed a minor increase and a larger planned reduction in share capital as of 3 June 2026. • New shares issued   On 2 June 2026, 102,000 ordinary shares were allotted upon...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"药明生物根据首次公开发售前期权发行0.10万股新股，4989万港元回购151万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"WUXI BIO (Cayman) Inc. disclosed a minor increase and a larger planned reduction in share capital as of 3 June 2026.\n• New shares issued  \nOn 2 June 2026, 102,000 ordinary shares were allotted upon exercise of Pre-IPO Share Option Scheme options at HKD 1.72 per share, expanding the issued share base by 0.00246 % to 4.14 billion shares.\n• Ongoing share buy-backs  \nBetween 27 May and 3 June 2026, the company bought back 7.47 million shares pending cancellation, including 1.51 million shares repurchased on-market on 3 June at prices between HKD 32.52 and HKD 33.82, for a total consideration of HKD 49.89 million.\nCumulatively, 30.65 million shares (0.75 % of the share capital authorised under the current mandate dated 6 June 2025) have been repurchased since the mandate’s adoption. A 30-day moratorium on new share issues runs until 3 July 2026.\n• Share capital position  \nIssued shares outstanding: 4,141.01 million  \nTreasury shares: none  \nShares pending cancellation from recent buy-backs: 7.47 million\nAll transactions were executed in compliance with Hong Kong Stock Exchange listing rules and the company’s repurchase mandate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113243608","isCrawlerRequest":true}